Anti-drug antibodies (ADAS)

Clinical trials for Anti-drug antibodies (ADAS) explained in plain language.

Never miss a new study

Get alerted when new Anti-drug antibodies (ADAS) trials appear

Sign up with your email to follow new studies for Anti-drug antibodies (ADAS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

New eye injection PRO-169 enters safety trial for Diabetes-Related vision loss

Disease control Not yet recruiting

This Phase 1 trial will test the safety of PRO-169, a form of bevacizumab injected into the eye, in 60 adults with diabetic macular edema. The study checks for immune reactions and side effects. It is not yet recruiting and focuses on safety, not whether it improves vision.

Matched conditions: ANTI-DRUG ANTIBODIES (ADAS)

Phase 1 • Sponsor: Laboratorios Sophia S.A de C.V. • Aim: Disease control

Last updated Jun 27, 2026 11:01 UTC

Anti-drug antibodies (ADAS)

Get alerted when new Anti-drug antibodies (ADAS) trials appear

New eye injection PRO-169 enters safety trial for Diabetes-Related vision loss